2018
Toward a normalized clinical drug knowledge base in China—applying the RxNorm model to Chinese clinical drugs
Wang L, Zhang Y, Jiang M, Wang J, Dong J, Liu Y, Tao C, Jiang G, Zhou Y, Xu H. Toward a normalized clinical drug knowledge base in China—applying the RxNorm model to Chinese clinical drugs. Journal Of The American Medical Informatics Association 2018, 25: 809-818. PMID: 29635469, PMCID: PMC7647010, DOI: 10.1093/jamia/ocy020.Peer-Reviewed Original ResearchConceptsChinese patent drugDrug knowledge basePatent drugsClinical drugsChemical drugsChinese drugsManual reviewChinese patent medicineElectronic health record systemsClinical dataChina's health insurance systemHealth record systemsDrug AdministrationHealth insurance systemDrug informationDrugsPatent medicineDrug namesRecord systemPharmacy system
2015
Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer
Zhang Y, Franzini L, Chan W, Xu H, Du X. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal Of Health Care For The Poor And Underserved 2015, 26: 1336-1358. PMID: 26548682, DOI: 10.1353/hpu.2015.0119.Peer-Reviewed Original ResearchConceptsRisk of mortalityColorectal cancerTumor stagePrivate health insuranceCancer patientsHealth insuranceCancer-directed surgeryColorectal cancer patientsTexas Cancer RegistryInsurance coverageAdditional private health insuranceBreast cancer patientsHealth insurance statusHealth insurance coverageOverall survivalCancer RegistryInsurance statusBreast cancerLarge cohortHigh riskMedicare beneficiariesPatientsCancerChemotherapySurgery